AbbVie
Amgen
AstraZeneca
BeiGene
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Innovent
Janssen Pharmaceuticals
Merck
Pfizer
Roche
Samsung Bio
Published | Pages | Publisher | Report code |
---|---|---|---|
May 2022 | 510 | Kuick Research | ASDR-601189 |
AbbVie
Amgen
AstraZeneca
BeiGene
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Innovent
Janssen Pharmaceuticals
Merck
Pfizer
Roche
Samsung Bio